4.5 Review

Pseudokinases: update on their functions and evaluation as new drug targets

Journal

FUTURE MEDICINAL CHEMISTRY
Volume 9, Issue 2, Pages 245-265

Publisher

FUTURE SCI LTD
DOI: 10.4155/fmc-2016-0207

Keywords

cancer; cysteine; cysteinome; disease; enzyme; inhibitor; kinase; kinome; pseudoenzyme; pseudokinase; signaling

Funding

  1. BBSRC [BB/N021703/1]
  2. BBSRC [BB/N021703/1] Funding Source: UKRI
  3. MRC [G120/1030] Funding Source: UKRI
  4. Biotechnology and Biological Sciences Research Council [BB/N021703/1] Funding Source: researchfish
  5. Medical Research Council [G120/1030] Funding Source: researchfish

Ask authors/readers for more resources

The pseudokinase complement of the human kinase superfamily consists of approximately 60 signaling proteins, which lacks one or more of the amino acids typically required to correctly align ATP and metal ions, and phosphorylate protein substrates. Recent studies in the pseudokinase field have begun to expose the biological relevance of pseudokinases, which are now thought to perform a diverse range of physiological roles and are connected to a multitude of human diseases, including cancer. In this review, we discuss how and why members of the `pseudokinome' represent important new targets for drug discovery, and describe how knowledge of protein structure and function provides informative clues to help guide the rational chemical design or repurposing of inhibitors to target pseudokinases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available